Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

DiaMedica Therapeutics (DMAC) Depreciation & Amortization (CF): 2017-2024

Historic Depreciation & Amortization (CF) for DiaMedica Therapeutics (DMAC) over the last 8 years, with Dec 2024 value amounting to $39,000.

  • DiaMedica Therapeutics' Depreciation & Amortization (CF) changed negligibly% to $5,000 in Q4 2019 from the same period last year, while for Dec 2019 it was $21,000, marking a year-over-year increase of 40.00%. This contributed to the annual value of $39,000 for FY2024, which is 30.00% up from last year.
  • DiaMedica Therapeutics' Depreciation & Amortization (CF) amounted to $39,000 in FY2024, which was up 30.00% from $30,000 recorded in FY2023.
  • In the past 5 years, DiaMedica Therapeutics' Depreciation & Amortization (CF) registered a high of $39,000 during FY2024, and its lowest value of $21,000 during FY2020.
  • For the 3-year period, DiaMedica Therapeutics' Depreciation & Amortization (CF) averaged around $31,333, with its median value being $30,000 (2023).
  • Data for DiaMedica Therapeutics' Depreciation & Amortization (CF) shows a peak YoY skyrocketed of 30.00% (in 2024) over the last 5 years.
  • Over the past 5 years, DiaMedica Therapeutics' Depreciation & Amortization (CF) (Yearly) stood at $21,000 in 2020, then climbed by 14.29% to $24,000 in 2021, then increased by 4.17% to $25,000 in 2022, then rose by 20.00% to $30,000 in 2023, then surged by 30.00% to $39,000 in 2024.